Skip to main content
. 2015 Oct 14;4(10):e001877. doi: 10.1161/JAHA.115.001877

Figure 4.

Figure 4

Odds of rt‐PA use at PSCs for (A) black patients, (B) Hispanic patients, and (C) Asian/Pacific Islander, Native American, and other patients, as compared to white patients. *Excluding the subgroup of interest, adjusted for: year, age, sex, primary expected payer, median income quartiles by ZIP code, region, teaching hospital, urban hospital location, volume of acute ischemic stroke annually at hospital, each of the 29 Agency for Healthcare Quality and Research (individual) comorbidities, and an APR‐DRG measure of disease severity to estimate the likelihood of dying during the hospitalization (minor, moderate, major, and extreme likelihoods of dying). APR‐DRG indicates all patient refined‐diagnosis related group; HMO, health maintenance organization; PSC, Primary Stroke Center; rt‐PA, recombinant tissue plasminogen activator.